The adoption of wearable technology in healthcare has been greatly accelerated by the COVID-19 pandemic, especially in remote monitoring and telemedicine. Wearables like smartwatches and medical-grade devices have become indispensable tools for managing chronic conditions, such as diabetes, by providing real-time glucose monitoring. Apple Watch users now have the ability to directly access glucose data from older DexCom continuous glucose monitoring (CGM) devices. This integration of wearables into medical practices is a significant development and eliminates previous reliance on iPhones for data relay, offering users seamless and immediate access to critical health information.
The wearable technology market is expected to experience significant growth in the coming years. With innovations in hearables and smartwatches, the market is projected to reach $290.6 billion by 2030, up from its current value of $99.5 billion in 2022. Advancements in AI are taking wearable devices to the next level, offering even more interactive and intelligent features. The latest Dexcom G7 from Dexcom showcases the growing trend of direct Bluetooth connectivity with smartphones and Apple Watch for real-time glucose monitoring. As healthcare professionals and patients increasingly embrace these technologies, they are reshaping diabetes management, fostering a connected and proactive approach beyond the pandemic.
